Your physician will guide this transition based on your response
However, recent landmark trials such as the FLOW study (2024) have demonstrated that semaglutide reduces the risk of major kidney events by 24% and major adverse CV events (MACE) by 18% in T2D patients with CKD, suggesting a paradigm shift in managing CV risk [20]
Dose Changes: ask whether the same price applies across dose adjustments or whether the provider uses dose-specific pricing
The question isnt whether GLP-1s will change the U.S
Umekwe N, Owei I, Stentz F, Dagogo-Jack S
What to do: Schedule regular GP check-ins or speak with one at Webdoctor Work with a registered dietitian to tailor your nutrition plan Avoid relying solely on medication combine with healthy eating and physical activity for best results Final Word and How Webdoctor.ie Can Help GLP-1 medications can be a helpful tool for weight management and diabetes care, but they work best when combined with the right diet, hydration, and physical activity